• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尼氯硝唑与羟乙基纤维素在二元和三元无定形固体分散体中的分子相互作用,协同提高水溶解度和大鼠口服药代动力学。

Molecular interactions of niclosamide with hydroxyethyl cellulose in binary and ternary amorphous solid dispersions for synergistic enhancement of water solubility and oral pharmacokinetics in rats.

机构信息

Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's NMIMS, V.L. Mehta Road, Vile Parle (W), Mumbai 400056, India.

PK-PD Toxicology Division, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu 180001, India.

出版信息

Int J Pharm. 2022 Oct 15;626:122144. doi: 10.1016/j.ijpharm.2022.122144. Epub 2022 Aug 25.

DOI:10.1016/j.ijpharm.2022.122144
PMID:36029996
Abstract

The cellulose-based polymers are extensively employed in oral formulations for addressing ADMET issues of API. Herein, we report the synergistic effect of hydroxyethyl cellulose in solubility/dissolution enhancement of BCS class II, anthelmintic drug niclosamide. The low solubility and poor oral bioavailability are the primary reasons for its high daily dose. The amorphous solid dispersions (ASDs) developed herein demonstrated reproducible solubility and dissolution enhancement in smaller-to-pilot batches. The significant boost in niclosamide solubility in HEC-based binary SD was rationalized as a result of intermolecular H-bonding as indicated by in-silico studies and further supported by characterization data. HEC is plausibly inhibiting the precipitation of drug and thereby enabling high dissolution and permeation across the membrane. The comparative oral pharmacokinetics in Wistar rats at 25 mg/kg provided 4.4-fold higher plasma exposure of niclosamide in SD formulation SB-ASD-N2 over the plain drug. The results presented herein warrant validation of this ASD under clinical settings.

摘要

基于纤维素的聚合物在口服制剂中被广泛用于解决 API 的 ADMET 问题。在此,我们报告了羟乙基纤维素在提高驱虫药硝氯酚(BCS Ⅱ类药物)溶解度/溶解速率方面的协同作用。低溶解度和差的口服生物利用度是其高日剂量的主要原因。本文所开发的无定形固体分散体(ASD)在较小规模到中试批次中显示出了重现性的溶解度和溶解速率提高。HEC 基二元 SD 中硝氯酚溶解度的显著提高可归因于分子间氢键,这一点通过计算机模拟研究得到了证实,并得到了表征数据的进一步支持。HEC 可能抑制了药物的沉淀,从而实现了高溶解速率和跨膜渗透。在 25mg/kg 剂量下,Wistar 大鼠的比较口服药代动力学研究表明,SD 制剂 SB-ASD-N2 中的硝氯酚的血浆暴露量比普通药物高 4.4 倍。本文的结果证明了这种 ASD 在临床环境下的验证是合理的。

相似文献

1
Molecular interactions of niclosamide with hydroxyethyl cellulose in binary and ternary amorphous solid dispersions for synergistic enhancement of water solubility and oral pharmacokinetics in rats.尼氯硝唑与羟乙基纤维素在二元和三元无定形固体分散体中的分子相互作用,协同提高水溶解度和大鼠口服药代动力学。
Int J Pharm. 2022 Oct 15;626:122144. doi: 10.1016/j.ijpharm.2022.122144. Epub 2022 Aug 25.
2
Amorphous Solid Dispersions and the Contribution of Nanoparticles to In Vitro Dissolution and In Vivo Testing: Niclosamide as a Case Study.无定形固体分散体以及纳米颗粒对体外溶出和体内测试的贡献:以氯硝柳胺为例的研究
Pharmaceutics. 2021 Jan 14;13(1):97. doi: 10.3390/pharmaceutics13010097.
3
Investigation into Intermolecular Interactions and Phase Behavior of Binary and Ternary Amorphous Solid Dispersions of Ketoconazole.酮康唑二元和三元无定形固体分散体的分子间相互作用和相行为研究。
Mol Pharm. 2020 Mar 2;17(3):787-801. doi: 10.1021/acs.molpharmaceut.9b00970. Epub 2020 Feb 20.
4
Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.无定形三元固体分散体的无定形稳定化与溶出度增强:具有药物 - 聚合物相互作用以产生协同效应的聚合物组合
J Pharm Sci. 2014 Nov;103(11):3511-3523. doi: 10.1002/jps.24137. Epub 2014 Sep 5.
5
Oral Delivery of Niclosamide as an Amorphous Solid Dispersion That Generates Amorphous Nanoparticles during Dissolution.作为一种无定形固体分散体的氯硝柳胺口服给药,该分散体在溶解过程中产生无定形纳米颗粒。
Pharmaceutics. 2022 Nov 23;14(12):2568. doi: 10.3390/pharmaceutics14122568.
6
Boost of solubility and supersaturation of celecoxib via synergistic interactions of methacrylic acid-ethyl acrylate copolymer (1:1) and hydroxypropyl cellulose in ternary amorphous solid dispersions.通过甲基丙烯酸-丙烯酸乙酯共聚物(1:1)与羟丙基纤维素在三元无定形固体分散体中的协同相互作用提高塞来昔布的溶解度和过饱和度
Int J Pharm X. 2022 Mar 24;4:100115. doi: 10.1016/j.ijpx.2022.100115. eCollection 2022 Dec.
7
Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System.喷雾干燥三元无定形固体分散体的固态特性和溶出特性研究:多组分无定形系统设计和开发的合理步骤。
Mol Pharm. 2018 Sep 4;15(9):3796-3812. doi: 10.1021/acs.molpharmaceut.8b00306. Epub 2018 Jul 30.
8
Solubility advantage from amorphous etoricoxib solid dispersions.无定形依托考昔固体分散体的溶解度优势。
Drug Dev Ind Pharm. 2014 Jan;40(1):92-101. doi: 10.3109/03639045.2012.749887. Epub 2013 Jan 10.
9
Stability and Bioavailability Enhancement of Telmisartan Ternary Solid Dispersions: the Synergistic Effect of Polymers and Drug-Polymer(s) Interactions.替米沙坦三元固体分散体的稳定性和生物利用度增强:聚合物和药物-聚合物相互作用的协同效应。
AAPS PharmSciTech. 2019 Mar 18;20(4):143. doi: 10.1208/s12249-019-1358-3.
10
Effect of hydroxypropylcellulose and Tween 80 on physicochemical properties and bioavailability of ezetimibe-loaded solid dispersion.羟丙甲纤维素和聚山梨酯 80 对载有依泽替米贝固体分散体的理化性质和生物利用度的影响。
Carbohydr Polym. 2015 Oct 5;130:26-31. doi: 10.1016/j.carbpol.2015.04.071. Epub 2015 May 12.

引用本文的文献

1
Transforming Niclosamide through Nanotechnology: A Promising Approach for Long COVID Management.通过纳米技术改造氯硝柳胺:一种治疗新冠后遗症的有前景的方法。
Small. 2025 Jul;21(27):e2410345. doi: 10.1002/smll.202410345. Epub 2025 May 19.
2
Revisiting Niclosamide Formulation Approaches - a Pathway Toward Drug Repositioning.重新审视氯硝柳胺制剂方法——药物再定位的途径。
Drug Des Devel Ther. 2024 Sep 17;18:4153-4182. doi: 10.2147/DDDT.S473178. eCollection 2024.
3
Physicochemical Characterization and In Vitro Activity of Poly(ε-Caprolactone)/Mycophenolic Acid Amorphous Solid Dispersions.
聚(ε-己内酯)/霉酚酸无定形固体分散体的物理化学表征及体外活性
Polymers (Basel). 2024 Apr 13;16(8):1088. doi: 10.3390/polym16081088.
4
Navigating the Solution to Drug Formulation Problems at Research and Development Stages by Amorphous Solid Dispersion Technology.利用无定形固体分散技术解决研发阶段的药物制剂问题。
Recent Adv Drug Deliv Formul. 2024;18(2):79-99. doi: 10.2174/0126673878271641231201065151.
5
Niclosamide as a Promising Therapeutic Player in Human Cancer and Other Diseases.尼氯硝唑——人类癌症及其他疾病治疗的新希望
Int J Mol Sci. 2022 Dec 17;23(24):16116. doi: 10.3390/ijms232416116.
6
Strategic developments in the drug delivery of natural product dihydromyricetin: applications, prospects, and challenges.天然产物二氢杨梅素药物传递的战略发展:应用、前景与挑战。
Drug Deliv. 2022 Dec;29(1):3052-3070. doi: 10.1080/10717544.2022.2125601.